BACKGROUND: IGF-I gene polymorphisms might alter IGF-I level resulting in decreased foetal and postnatal growth and increased risk for diabetes mellitus type 2 and cardiovascular diseases in adulthood. OBJECTIVES: We analyzed the association between Cytosine-Adenosine (CA)10-24 repeats polymorphism in promoter region of the IGF-I gene and early growth in infants with birth weight appropriate for gestational age (AGA) and small for gestational age (SGA). Design and METHODS: All neonates were born at term, 196 of them were AGA and 26 SGA. Blood for DNA analyses was obtained from placental part of umbilical vein. Genotyping was performed using fragment analyses of IGF-I gene promoter region. The data about postnatal growth in the group of AGA children were obtained at the age of 18 months, in SGA children at 12 months. RESULTS: No differences in the frequency of wild type allele with (CA)19 repeats and polymorphisms with (CA)<19 or (CA)>19 repeats were observed between AGA and SGA children. The average birth weight and length in AGA wild type (CA)19 homozygotes were lower in comparison with AGA carriers of various (CA)n polymorphisms but all observed anthropometric differences disappeared at the age of 18 months. In SGA children, no differences were found between number of (CA)n repeats and anthropometric parameters both at birth and at the age of 12 months. CONCLUSIONS: Although (CA)n repeats polymorphism in IGF-I gene might affect prenatal growth in AGA children, our results have not shown any impact of variable number of (CA) n repeats in IGF-I gene on postnatal growth.

Department of Paediatrics Charles University Prague Czech Republic

000      

03434naa a2200517 a 4500

001      

bmc12009097

003      

CZ-PrNML

005      

20140717103141.0

008      

120319s2009 sw eng||

009      

AR

040    __

$d ABA008 $a ABA008 $b cze

041    0_

$a eng

044    __

$a sw

100    1_

$a Kytnarová, Jitka, $d 1964- $7 nlk20040146963 $u Department of Paediatrics, Charles University in Prague, Czech Republic

245    10

$a Cytosine-Adenosine (CA)n repeats polymorphism in IGF-I gene and early growth in infants born appropriate and small for gestational age / $c J. Kytnarova, K. Vesela, B. Zlatohlavkova, A. Dohnalova, M. Fedorova, M. Krsek, J. Zeman

520    9_

$a BACKGROUND: IGF-I gene polymorphisms might alter IGF-I level resulting in decreased foetal and postnatal growth and increased risk for diabetes mellitus type 2 and cardiovascular diseases in adulthood. OBJECTIVES: We analyzed the association between Cytosine-Adenosine (CA)10-24 repeats polymorphism in promoter region of the IGF-I gene and early growth in infants with birth weight appropriate for gestational age (AGA) and small for gestational age (SGA). Design and METHODS: All neonates were born at term, 196 of them were AGA and 26 SGA. Blood for DNA analyses was obtained from placental part of umbilical vein. Genotyping was performed using fragment analyses of IGF-I gene promoter region. The data about postnatal growth in the group of AGA children were obtained at the age of 18 months, in SGA children at 12 months. RESULTS: No differences in the frequency of wild type allele with (CA)19 repeats and polymorphisms with (CA)<19 or (CA)>19 repeats were observed between AGA and SGA children. The average birth weight and length in AGA wild type (CA)19 homozygotes were lower in comparison with AGA carriers of various (CA)n polymorphisms but all observed anthropometric differences disappeared at the age of 18 months. In SGA children, no differences were found between number of (CA)n repeats and anthropometric parameters both at birth and at the age of 12 months. CONCLUSIONS: Although (CA)n repeats polymorphism in IGF-I gene might affect prenatal growth in AGA children, our results have not shown any impact of variable number of (CA) n repeats in IGF-I gene on postnatal growth.

590    __

$a bohemika - dle Pubmed

650    02

$a adenosin $7 D000241

650    02

$a porodní hmotnost $x genetika $7 D001724

650    02

$a tělesná výška $x genetika $7 D001827

650    02

$a vývoj dítěte $x fyziologie $7 D002657

650    02

$a cytosin $7 D003596

650    02

$a ženské pohlaví $7 D005260

650    02

$a lidé $7 D006801

650    02

$a kojenec $7 D007223

650    02

$a novorozenec $7 D007231

650    02

$a hypotrofický novorozenec $x fyziologie $x růst a vývoj $7 D007236

650    02

$a insulinu podobný růstový faktor I $x genetika $7 D007334

650    02

$a mužské pohlaví $7 D008297

650    02

$a polymorfismus genetický $7 D011110

650    02

$a promotorové oblasti (genetika) $x genetika $7 D011401

650    02

$a repetitivní sekvence nukleových kyselin $7 D012091

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Veselá, Kateřina, $d 1965- $7 mzk2008472898

700    1_

$a Zlatohlávková, Blanka, $7 jx20070510017 $d 1954-

700    1_

$a Dohnalová, Alena $7 xx0062948

700    1#

$a Fedorová, Maria. $7 _BN006662

700    1_

$a Kršek, Michal $7 xx0046428

700    1_

$a Zeman, Jiří, $d 1950- $7 skuk0001517

773    0_

$t Neuroendocrinology Letters $p Neuroendocrinol Lett $g Roč. 30, č. 4 (2009), s. 501-505 $x 0172-780X $w MED00168352

773    0_

$p Neuroendocrinol Lett $g 30(4):501-5, 2009 $x 0172-780X

910    __

$a ABA008 $b x $y 4 $z 0

990    __

$a 20120319150855 $b ABA008

991    __

$a 20140717103443 $b ABA008

999    __

$a ok $b bmc $g 902321 $s 766003

BAS    __

$a 3

BMC    __

$a 2009 $b 30 $c 4 $d 501-505 $i 0172-780X $m Neuro-endocrinology letters $x MED00168352

GRA    __

$a NR9374 $p MZ0

LZP    __

$a 2012-1Q10/